Women's healthcare vendor Hologic of Bedford, MA, has acquired Interlace Medical of Framingham, MA, for $125 million in cash.
Interlace developed and manufactures the MyoSure hysteroscopic tissue removal system, which is designed to provide incisionless and safe removal of intracavitary fibroids and polyps, providing patients with relief from associated abnormal uterine bleeding symptoms.
Interlace's operations will be integrated within Hologic's GYN Surgical Products division. Steve Williamson, senior vice president and general manager of GYN Surgical Products, said MyoSure is an extension of Hologic's ob/gyn product portfolio, which provides women with minimally invasive treatment options.
The all-cash transaction is subject to adjustment and two annual contingent payments. Each payment will be calculated as a multiple of the incremental revenue growth over the prior year.
Related Reading
Hologic teams with SuperSonic Imagine, November 24, 2010
Hologic's Selenia nets FDA letter, November 23, 2010
Hologic posts mixed results for FY 2010, November 9, 2010
Hologic reports 5-year MammoSite results, November 2, 2010
FDA panel gives nod to Hologic tomosynthesis PMA, September 24, 2010
Copyright © 2011 AuntMinnie.com
